Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diwei Zheng

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 25, 2026
Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic FunctionJinghui Wang, Wenxuan Zhao, Xiaoming Hu, et al.
International Journal of Biological Macromolecules|January 19, 2016
pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticlesHongyu Chen, Diwei Zheng, Jia Liu, et al.
Biomarker Research|February 4, 2020
PSCA is a target of chimeric antigen receptor T cells in gastric cancerDi Wu, Jiang Lv, Ruocong Zhao, et al.
Cell Reports. Medicine|January 21, 2026
Engineered Akkermansia muciniphila vesicles for targeted pyroptosis and trained immunity to enhance immunotherapy in hepatocellular carcinomaLanxiang Huang, Yuan Rong, Minghui Guo, et al.
ACS Nano|June 28, 2019
Nanoparticles from Cuttlefish Ink Inhibit Tumor Growth by Synergizing Immunotherapy and Photothermal TherapyRong-Hui Deng, Mei-Zhen Zou, Diwei Zheng, et al.
Molecular Therapy. Oncology|June 17, 2024
Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinomaLinfu Zhou, Yao Li, Diwei Zheng, et al.
Signal Transduction and Targeted Therapy|January 20, 2021
AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcomaDiwei Zheng, Weihai Liu, Wenlin Xie, et al.
Frontiers in Immunology|April 19, 2021
Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86-Positive B Cell MalignanciesShouheng Lin, Lin Cheng, Wei Ye, et al.
Clinical and Experimental Medicine|December 10, 2022
CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancerMing Li, Shanglin Li, Ruocong Zhao, et al.
Nano Letters|September 28, 2019
Epigenetics-Based Tumor Cells Pyroptosis for Enhancing the Immunological Effect of Chemotherapeutic NanocarriersJin-Xuan Fan, Rong-Hui Deng, He Wang, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 25, 2026
Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic FunctionJinghui Wang, Wenxuan Zhao, Xiaoming Hu, et al.
International Journal of Biological Macromolecules|January 19, 2016
pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticlesHongyu Chen, Diwei Zheng, Jia Liu, et al.
Biomarker Research|February 4, 2020
PSCA is a target of chimeric antigen receptor T cells in gastric cancerDi Wu, Jiang Lv, Ruocong Zhao, et al.
Cell Reports. Medicine|January 21, 2026
Engineered Akkermansia muciniphila vesicles for targeted pyroptosis and trained immunity to enhance immunotherapy in hepatocellular carcinomaLanxiang Huang, Yuan Rong, Minghui Guo, et al.
ACS Nano|June 28, 2019
Nanoparticles from Cuttlefish Ink Inhibit Tumor Growth by Synergizing Immunotherapy and Photothermal TherapyRong-Hui Deng, Mei-Zhen Zou, Diwei Zheng, et al.
Molecular Therapy. Oncology|June 17, 2024
Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinomaLinfu Zhou, Yao Li, Diwei Zheng, et al.
Signal Transduction and Targeted Therapy|January 20, 2021
AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcomaDiwei Zheng, Weihai Liu, Wenlin Xie, et al.
Frontiers in Immunology|April 19, 2021
Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86-Positive B Cell MalignanciesShouheng Lin, Lin Cheng, Wei Ye, et al.
Clinical and Experimental Medicine|December 10, 2022
CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancerMing Li, Shanglin Li, Ruocong Zhao, et al.
Nano Letters|September 28, 2019
Epigenetics-Based Tumor Cells Pyroptosis for Enhancing the Immunological Effect of Chemotherapeutic NanocarriersJin-Xuan Fan, Rong-Hui Deng, He Wang, et al.
Pageof 5